Wipro in focus on multi-year engagement

Wipro said that it has been awarded a strategic multi-year cyber governance, cloud and infrastructure services transformation engagement by Olympus. Headquartered in Tokyo, Olympus is a global medtech company committed to Making people's lives healthier, safer and more fulfilling.

Raymond said it has allotted 33,38,278 Equity Shares at a price of Rs 674 per Equity Share aggregating to approximately Rs 225 crore and 18,54,599 0.01% Compulsorily Convertible Preference Shares, each carrying a right to convert to one Equity Share per Preference Share, at a price of Rs 674 per Preference Share, aggregating to approximately Rs 125 crore, on preferential basis to J. K. Investo Trade (India) Limited.

Biocon and Equillium Inc. a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, announced that they have expanded their collaboration and license agreement for itolizumab to grant Equillium exclusive rights for developing and commercializing itolizumab in Australia and New Zealand. Equillium had originally secured exclusive rights to develop and commercialize Biocon's novel biologic, itolizumab, for the U.S. and Canada markets, in May 2017.

Bank of Baroda said it has issued and allotted 65,14,65,798 equity shares of Rs 2/- each fully paid up at an issue price of Rs 107.45 per equity share (premium of Rs 105.45 per share) aggregating to Rs 7,000 crore to Government of India (Promoter) on preferential basis. Bank of Baroda has also signed the binding Share Purchase Agreement for sale of business of Bank of Baroda (Trinidad & Tobago) Limited (BOBTTL) with Ansa Merchant Bank Ltd., subject to regulatory approval.

Navin Fluorine International said the company is planning a capex program at Dahej (Gujarat) through a wholly owned subsidiary with an estimated aggregate capital outlay of over Rs 450 crore over the next 3 - 4 years. The Board of Directors has initially approved capital expenditure of approx. Rs. 90 crore for site development and related infrastructure on approx. 74 acres of land for greenfield projects at Dahej through a wholly owned subsidiary. The said capital expenditure will be funded out of its internal accruals. The development of the infrastructure will enable the Company to set up various future greenfield projects in fluorochemicals.

Infosys said its subsidiary, EdgeVerve Systems, announced partnership with IDEGO, a leading consulting firm for digital transformation, to develop and deliver innovative tech products to their customers across Latin America. Together, they will assist enterprises across telecom and financial services to help improve enterprise-wide productivity and efficiency.

Powered by Capital Market - Live News